Circulating Biomarkers for Cardiovascular Disease Risk Prediction in Patients With Cardiovascular Disease
Cardiovascular disease (CVD) is the leading cause of death globally. Risk assessment is crucial for identifying at-risk individuals who require immediate attention as well as to guide the intensity of medical therapy to reduce subsequent risk of CVD. In the past decade, many risk prediction models h...
Main Authors: | Yuen-Kwun Wong, Hung-Fat Tse |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.713191/full |
Similar Items
-
High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus
by: Yuen-Kwun Wong, et al.
Published: (2019-12-01) -
Editorial: Cardiac rhythmology case reports: Abnormal ECG and beyond
by: Chun-Ka Wong, et al.
Published: (2022-08-01) -
Predictive value of visit-to-visit blood pressure variability for cardiovascular events in patients with coronary artery disease with and without diabetes mellitus
by: Yuen-Kwun Wong, et al.
Published: (2021-04-01) -
Clinical Significance of Increased Cardiac Troponin T in Patients with Chronic Hemodialysis and Cardiovascular Disease: Comparison to B-Type Natriuretic Peptide and A-Type Natriuretic Peptide Increase
by: Shinichiro Niizuma, et al.
Published: (2019-09-01) -
Inflammageing and Cardiovascular System: Focus on Cardiokines and Cardiac-Specific Biomarkers
by: Marco Alfonso Perrone, et al.
Published: (2023-01-01)